Study Highlights Long-Term Efficacy of Ritlecitinib in Alopecia Areata Dr. Shravani Dali18 Feb 2025 8:45 PM ISTResearch suggests that ritlecitinib is effective for long-term treatment in patients with alopecia areata who have greater than or equal to 25% scalp...
Active ritlecitinib may improve hair growth in patients with alopecia areata: Study Jacinthlyn Sylvia7 Oct 2024 8:00 PM ISTA new study published in the journal of Dermatology suggests that the Alopecia areata patients who were receiving doses of active ritlecitinib...
Top Ten US-FDA Approved Pharmacological Agents in 2023: A Year in Review MDTV Bureau30 Dec 2023 3:51 PM ISTWe come to the end of 2023. Here are top ten pharmacological agents that received US-FDA approval throughout this year, across key therapy areas:1)...
European Commission approves ritlecitinib for severe Alopecia areata Dr. Kamal Kant Kohli23 Sept 2023 9:45 AM ISTThe European Commission has authorized the marketing of ritlecitinib for treatment of severe alopecia areata for adolescents and adults . ...
Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata Ruchika Sharma21 Sept 2023 3:30 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat...
Generate Phase II Clinical Data on 20 Indian subjects for dose selection: CDSCO panel Tells Pfizer on Ritlecitinib Dr. Divya Colin10 Sept 2023 6:00 PM ISTNew Delhi: Noting that in the presented Phase II clinical trial data, no Indian subjects were involved and the study disease is very heterogeneous,...
FDA approves first oral JAK inhibitor for treatment of alopecia areata in adolescents Medha Baranwal28 Jun 2023 8:00 PM ISTUSA: The US FDA (Food and Drug Administration) has approved ritlecitinib (Litfulo), a Janus kinase (JAK) inhibitor, for adults and adolescents with...
Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA Ruchika Sharma24 Jun 2023 11:30 AM ISTLITFULO is a kinase inhibitor which inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of...
Ritlecitinib safe treatment option for alopecia areata in adults and adolescents: Lancet Medha Baranwal24 April 2023 11:30 AM ISTUSA: A recent study published in The Lancet has projected ritlecitinib to be an appropriate treatment option for alopecia areata in individuals who...
Submit Phase II CT safety data: CDSCO panel tells Pfizer over Ritlecitinib Dr. Divya Colin27 Feb 2023 6:00 PM ISTNew Delhi: Denying the proposal presented by the pharma major Pfizer for Phase III CT of the drug Ritlecitinib, the Subject Expert Committee (SEC)...
USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib Ruchika Sharma10 Sept 2022 5:15 PM ISTAlopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...
Ritlecitinib and brepocitinib improve scalp alopecia areata biomarkers: Study Medha Baranwal22 Dec 2021 9:00 AM ISTUSA: Ritlecitinib and brepocitinib both showed an significant improvement in scalp alopecia areata (AA) biomarkers, finds a recent...
